Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Clotting Disorders

December 20, 2021

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

Keywords:

Researchers Identify Risk Factors for Venous Thromboembolism in Women with Obesity Who Undergo Cesarean Delivery

Obstetricians recognize that the prevalence and morbidity of venous thromboembolism (VTE) in the peripartum period contributes significantly to maternal death. New research indicates ...

Caplacizumab Improves ADAMTS13 Recovery in Patients with iTTP

Caplacizumab, a humanized nanobody, blocks the interaction between von Willebrand factor and platelets. While early administration of caplacizumab in patients with the rare disease immune ...

Apixaban Produces More Favorable Results Than Rivaroxaban, Warfarin in AF, VTE

In patients on direct oral anticoagulants (DOACs) for atrial fibrillation (AF) and venous thromboembolism (VTE), treatment with apixaban resulted in less bleeding and was associated with ...

No Change in Platelet Count Threshold of Patients With ITP Treated With Aspirin

Patients with immune thrombocytopenia (ITP) and a platelet count of less than 20 × 109/L who were treated with aspirin experienced bleeding at similar rates as patients with ITP who were ...

Study Suggests Iron Homeostasis Is Key in Pregnancy Outcomes in Thalassemic Mice

Adverse pregnancy outcomes in thalassemic (Th3/+) mice, such as placenta enlargement and growth restriction, could be related to iron overload in a way not previously appreciated ...

Site of Cancer Could Predict VTE Recurrence After Anticoagulation Cessation

Despite having active cancer, patients who have surgery-associated venous thromboembolism (VTE) may only require time-limited anticoagulation ...

Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP

Recombinant ADAMTS13 (rADAMTS13) plus plasma exchange increased ADAMTS13 exposure in patients with immune-​mediated thrombotic thrombocytopenic purpura (iTTP) compared with placebo plus plasma exchange ...

Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP

An interim analysis of the open-label extension ADVANCE+ study suggests that long-term efgartigimod has an acceptable side effect profile and is not associated with increased exposure-adjusted risk ...

Silent Cerebral Infarction During iTTP Can Affect Cognition

Silent cerebral infarction (SCI) refers to the often-​incidental finding of brain infarction in the absence of overt neurologic deficits. Magnetic resonance imaging (MRI) evidence suggests that ...

COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs

A cross-sectional study of U.S. safety data found few hematologic adverse events (AEs) after administration of the authorized COVID-19 bivalent booster vaccines from Pfizer-BioNTech and Moderna ...

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
December 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals